price is 50 days old and had prostate surgery a year ago. Radical retropubic prostatectomy is classicly performed on men with early-podium prostate blight. some months ago price had his nine-month stake-surgery PSA (prostate-explicit antigen) blood analysis.

My one-year sense was above what is classic, says price, but my surgeon thinks this is due to some prostate hankie that was left after surgery. Ive ongoing pleasing supplements, and Ill have more checkups, just to make loyal.

The most frequently diagnosed blight in Canadian males and the third most shared reason of blight-connected demise in men is prostate blight. Bereason it is such a gradual-mounting blight, it may never reason symptoms and is regularly only detectable by a PSA blood analysis, which mealoyals levels of PSA, an enzyme formed by the prostate.

As we take the journey through the final part of this article, you can look back at the first part if you need any clarifications on what we have already learned.

However, new explore suggests that the analysis may answer in overdiagnosis bereason it detects blights that would never become life threatening. Some men with prostate blight do not have an lofty PSA, and many men with an lofty PSA do not have prostate blight. Some exploreers even declare that if a man lives long enough, his prostate will eventually stem blight.Researchers are unsure what causes prostate cancer, but are learning what may slow its progress and perhaps prevent its onset. In 2000 a case-controlled study on the anticancer properties of legumes indicated that consumption of legumes lowered rates of prostate cancer. Numerous studies have shown that phytochemicals, such as the isoflavones genistein and daidzein, found especially in soy products, have anticancer properties. Soy products also contain protease inhibitors, phytic acid, lignans, phytosterols, and saponins, all of which appear to inhibit carcinogenesis.

Recently, research on prostate cancer has focused on the marriage of genetics and diet in a new arena of study called nutrigenomics. This new science seeks to understand how diet affects genetics, and researchers hope to someday design diets that delay the onset of genetically based disease. Prostate cancer has been the poster child for this type of research because of its high incidence and the relative longevity of the patients.

One of the largest prostate cancer studies ever conducted was the SELECT (Selenium and Vitamin E Cancer Prevention Trial) study, which included over 35,000 men. The study was designed to discover if selenium and vitamin E could prevent prostate cancer. While the jury may be out on its ability to prevent prostate cancer, selenium has been shown to enhance the efficacy of conventional medical cancer treatments by preventing the body’s resistance to the drugs.

Since his treatment ended, Bill has made changes in his life. “I take a vitamin mix that includes selenium, vitamin E, beta carotene, and vitamin C. I started drinking green tea instead of coffee, and I hit the gym three times a week to lift weights. I’m ready for the next 50 years.”

What’s a Normal PSA?

Normal blood levels of PSA depend on age and medical history.

• 3 or less is normal for men under 60
• 4 or less for ages 60-69
• 5 or less for over 70

A reading over 10 can indicate cancer or a benign infection. Men should discuss the limitations of the test—especially false-positive readings—with their health care professional.

See “Biochemical (PSA) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate CA,” The Journal of Urology (2003), at
cancerprostatehelp.org/download/jhnomo.pdf.

See also “High Prevalence of Complementary and Alternative Medicine Use Among Cancer Patients: Implications for Research and Clinical Care,” The Journal of Clinical Oncology (2005), at prostatehelp.blogs.com/prostatehelp/2005/04/high_prevalence.html.

For recent research on the PSA test, see “Assessing Risk: Does This Patient Have Prostate Cancer?” Journal of the National Cancer Institute (2006), at jnci.oxfordjournals.org/cgi/reprint/98/8/506.

For more on the role of soy see “Soybean Phytochemicals Inhibit the Growth of Transplantable Human Prostate Carcinoma and Tumor Angiogenesis in Mice” (1999), at jn.nutrition.org/cgi/reprint/129/9/1628.

See also the section on prostate cancer in “Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections” from Belgium’s Ghent University (2004), available at